These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 11221033)

  • 1. [Does PSA density of the transition zone represent a useful parameter in the diagnosis of prostate carcinoma?].
    Monesi G; Sala M; Baietto S; Minocci D; Kocjancic E; Marchioro G; Frea B
    Arch Ital Urol Androl; 2000 Dec; 72(4):182-9. PubMed ID: 11221033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [PSA level of the transitional zone: a new marker especially reliable for the detection of prostatic cancer].
    Roumeguere T; Zlotta AR; Djavan BR; Marberger M; Schulman CC
    Acta Urol Belg; 1997 Mar; 65(1):5-9. PubMed ID: 9245203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity and accuracy of TRUS-measured PSA-density and transition zone-PSA in the diagnosis of prostate cancer.
    Michielsen DP; De Boe VR; Braeckman JG; Keuppens FI
    Eur J Ultrasound; 1998 Nov; 8(2):125-8. PubMed ID: 9845794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of specificity in PSA-based screening by using PSA-transition zone density and percent free PSA in addition to total PSA levels.
    Horninger W; Reissigl A; Klocker H; Rogatsch H; Fink K; Strasser H; Bartsch G
    Prostate; 1998 Nov; 37(3):133-7; discussion 138-9. PubMed ID: 9792130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Validity of PSA density of the transition zone in the diagnosis of prostate cancer].
    Anastasi G; Magno C; Carmignani A; Inferrera A; Petrelli A; Broccio G
    Arch Ital Urol Androl; 2000 Dec; 72(4):190-3. PubMed ID: 11221034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
    Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
    J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?
    Abdel-Khalek M; Sheir KZ; El-Baz M; Ibrahiem el-H
    Scand J Urol Nephrol; 2005; 39(1):49-55. PubMed ID: 15764271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PSA density and PSA transition zone density in the diagnosis of prostate cancer in PSA gray zone cases.
    Aksoy Y; Oral A; Aksoy H; Demirel A; Akcay F
    Ann Clin Lab Sci; 2003; 33(3):320-3. PubMed ID: 12956448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of 3D-ultrasonography in the assessment of transitional zone PSA].
    Pierangeli T; Muraro GB
    Arch Ital Urol Androl; 2002 Dec; 74(4):282-4. PubMed ID: 12508752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
    Horiguchi A; Nakashima J; Horiguchi Y; Nakagawa K; Oya M; Ohigashi T; Marumo K; Murai M
    Prostate; 2003 Jun; 56(1):23-9. PubMed ID: 12746843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate specific antigen adjusted for transition zone epithelial volume: the powerful predictor for the detection of prostate cancer on repeat biopsy.
    Ohigashi T; Kanao K; Kikuchi E; Nakagawa K; Nakashima J; Marumo K; Murai M
    J Urol; 2005 May; 173(5):1541-5. PubMed ID: 15821482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of prostate specific antigen complexed to alpha1-antichymotrypsin to avoid unnecessary biopsy in patients with serum prostate specific antigen levels 4-20 ng/mL.
    Nakano Y; Okamura K; Takamura S; Okamoto N; Narishima M; Yoshino Y; Hattori R; Ono Y; Ohshima S; Nagasaka T
    Int J Urol; 2005 Aug; 12(8):721-7. PubMed ID: 16174045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less.
    Zlotta AR; Remzi M; Snow PB; Schulman CC; Marberger M; Djavan B
    J Urol; 2003 May; 169(5):1724-8. PubMed ID: 12686818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence.
    Rahardjo D; Kamil ST; Pakasi LS
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():563-70. PubMed ID: 10895211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum prostate-specific antigen as surrogate for the histological diagnosis of prostate cancer.
    Heyns CF; Naudé AM; Ahmed G; Stopforth HB; Stellmacher GA; Visser AJ
    S Afr Med J; 2001 Aug; 91(8):685-9. PubMed ID: 11584785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting CAP in patients with intermediate PSA using modified PSA indices.
    Zisman A; Leibovici D; Kleinmann J; Siegel YI; Lindner A
    Can J Urol; 2000 Dec; 7(6):1144-8. PubMed ID: 11151095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of artificial neural network analysis to improve the predictive accuracy of prostate biopsy in the Japanese population.
    Matsui Y; Utsunomiya N; Ichioka K; Ueda N; Yoshimura K; Terai A; Arai Y
    Jpn J Clin Oncol; 2004 Oct; 34(10):602-7. PubMed ID: 15591458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
    Iwaki H; Kajita Y; Shimizu Y; Yamauchi T
    Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of prostate-specific antigen testing in patients with prostate disease.
    Yu HJ; Chie WC; Hsieh CH; Tsai CC; Lai MK
    J Formos Med Assoc; 1996 Oct; 95(10):782-8. PubMed ID: 8961676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of percent free prostate specific antigen, prostate specific antigen density of the whole prostate and of the transition zone in Turkish men.
    Akduman B; Alkibay T; Tuncel A; Bozkirli I
    Can J Urol; 2000 Oct; 7(5):1104-9. PubMed ID: 11114873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.